Ciputra Development Tbk vs Charlie Hospital Semarang Tbk. — how do they compare? Ciputra Development Tbk trades at Rp575 (market cap 10.38T, 17.29M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 25.57M 24h volume). The key difference: Ciputra Development Tbk is far larger — about 15.3× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.57M versus 17.29M). Which is the better fit depends on your goals.
| CTRA | RSCH | |
|---|---|---|
Market Cap | 10.38T | 678.4B |
Volume | 17.29M | 25.57M |
Lot | 172.91K | 255.67K |
Turnover | 9.94B | 6.57B |
Average Price | 575.1 | 256.8 |
Value | 9.94B | 6.57B |
Indicative Equilibrium Price | 575 | 258 |
Indicative Equilibrium Volume | 12.39K | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Read more on CTRA →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →